Insider · CIK 0001326192
Adrienne L Graves
director
Files at IRD (Opus Genetics, Inc.), HROW (HARROW, INC.), OCUL (OCULAR THERAPEUTIX, INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | IRD Opus Genetics, Inc. | AGrant or award Common Stock | +23,643 | - | - | 103,147 | Jan 5, 2026 |
| Jun 20, 2025 | HROW HARROW, INC. | AGrant or award RSUderivative | +7,339 | $0.00 | $0 | 7,339 | Jun 24, 2025 |
| Jun 11, 2025 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +14,000 | $0.00 | $0 | 50,000 | Jun 13, 2025 |
| Jun 11, 2025 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 13, 2025 |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | AGrant or award Common Stock | +79,504 | $0.00 | $0 | 79,504 | May 2, 2025 |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +79,592 | $0.00 | $0 | 79,592 | May 2, 2025 |
| Oct 22, 2024 | IRD Opus Genetics, Inc. | AGrant or award Stock Option (right to buy)derivative | +172,874 | $0.00 | $0 | 172,874 | Oct 24, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.